110
Views
2
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

Identification and characteristics of imipenem-resistant Acinetobacter baumannii in surgical wards in a Chinese university hospital

, , , , , & show all
Pages 182-186 | Received 19 May 2014, Accepted 14 Oct 2014, Published online: 22 Jan 2015

References

  • Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 2008;28:15–25.
  • Bayuga S, Zeana C, Sahni J, Della-Latta P, el-Sadr W, Larson E. Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again. Heart Lung 2002;31:382–90.
  • Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, Yu Y, et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother 2010;65:644–50.
  • Queenan A, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007;20:440–58.
  • Unal S, Garcia-Rodriguez JA. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004. Diagn Microbiol Infect Dis 2005;53:265–71.
  • Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010;35:219–26.
  • Brown S, Amyes S. OXA-beta-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 2006;57:1–3.
  • Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009;53:5035–8.
  • Zhou H, Yang Q, Yu YS, Wei ZQ, Li LJ. Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China. J Clin Microbiol 2007;45:4054–7.
  • Fu Y, Jiang J, Zhou H, Jiang Y, Fu Y, Yu Y, et al. Characterization of a novel plasmid type and various genetic contexts of blaOXA-58 in Acinetobacter spp. from multiple cities in China. Plos One 2014;9:e84680.
  • Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005;43:1632–9.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th information supplement. CLSI document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
  • Ramana KV, Rao R, Sharada ChV, Kareem M, Reddy LR, Ratna Mani M. Modified Hodge test: a useful and the low-cost phenotypic method for detection of carbapenemase producers in Enterobacteriaceae members. J Nat Sci Biol Med 2013;4:46–8.
  • Gaynes R, Edwards JR. National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41: 848–54.
  • Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007;51:4022–8.
  • Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:410–19.
  • Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, et al. Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005. Chin J Med 2007;87:2753–8 (abstract in Chinese).
  • Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006;258:72–7.
  • Wang H, Chen M. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to2002. Diagn Microbiol Infect Dis 2005;51:201–8.
  • Xu J, Sun Z, Li Y, Zhou Q. Surveillance and correlation of antibiotic consumption and resistance of Acinetobacter baumannii complex in a tertiary care hospital in northeast China, 2003-2011. Int J Environ Res Public Health 2013;10:1462–73.
  • Ben Othman A, Zribi M, Masmoudi A, Abdellatif S, Ben Lakhal S, Fendri C. Multiresistance and endemic status of Acinetobacter baumannii associated with nosocomial infections in a Tunisian hospital: a critical situation in the intensive care units. Braz J Microbiol 2011;42:415–22.
  • Safari M, Saidijam M, Bahador A, Jafari R, Alikhani MY. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter Baumannii isolated from patients in ICU wards, Hamadan, Iran. J Res Health Sci 2013;13:162–7.
  • Li B, Li M, Li Qu, Wang M, Guo J. Prevalence and characteristics of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from pediatric inpatients with respiratory tract infections at a teaching hospital in China. Scand J Infect Dis 2014;46:200–3.
  • Ruan Z, Chen Y, Jiang Y, Zhou H, Zhou Z, Fu Y, et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents 2013;42:322–8.
  • Zhou Z, Du X, Wang L, Yang Q, Fu Y, Yu Y. Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China. Antimicrob Agents Chemother 2011;55:5347–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.